Find in Library
Search millions of books, articles, and more
Indexed Open Access Databases
Carbimazole-induced cholestatic hepatitis in Graves′ disease
oleh: Sunil K Kota, Lalit K Meher, Siva K Kota, Sruti Jammula, Kirtikumar D Modi
Format: | Article |
---|---|
Diterbitkan: | Wolters Kluwer Medknow Publications 2013-01-01 |
Deskripsi
Antithyroid medications are one of the treatment options for Graves′ disease. Carbimazole is widely used as the drug of choice, except in pregnancy, where propythiouracil is preferred by many. It is generally well-tolerated. Its side-effects include allergy, upper gastrointestinal upset, a rare occurrence of granulocytosis, and others. Hepatitis is another rare, but serious side-effect. We report a healthy 30-year-old male patient with Graves′ disease, who developed cholestatic jaundice after Carbimazole therapy for four months. He made a full recovery after the drug was discontinued. An idiosyncratic mechanism seemed likely.